Logo RadNet, Inc.

RadNet, Inc. (RDNT) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
RadNet, Inc. · Health Care · ref. ETF XLV · 51 calls · price $75.36
💬JPI AI AssistantTry it →
What the company does: RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally.

📈 RadNet, Inc. (RDNT) stock price

$75.36+5.0% over range
Aug 28, 25low $51.87 · high $84.48Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 2 analysts
📊 JPI status : RadNet, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 RDNT price target & analyst consensusprice $75.36

The price target · all analysts combined (2 targets)
Highest target · 1 firm of 2$94+24.7%
Median target · of 2 targets$79.5+5.5%
Lowest target · 1 firm of 2$65-13.7%
Current price$75.36
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 2 ratings (last 6 months)
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about RadNet, Inc.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on RDNT

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Raymond James  82% +34.2% 11
Truist Securities  80% +24.8% 10
Barclays  80% +3.1% 5
Jefferies  67% +10.6% 6
Sidoti & Co. 60% +11.8% 5
B. Riley Securities  0% -21.0% 2

📊 What $1,000 invested in RadNet, Inc. would be worth › open the full page

In short — $1,000 invested in RadNet, Inc. 10 years ago would be worth $10,159 today, i.e. +26%/yr on average. Best year: 2024 (+101%), worst: 2022 (-37%). Price performance, excluding dividends.

If I'd invested $1,000 in RadNet, Inc.

InvestmentWorth todayGain
1 years ago$899-10%
3 years ago$3,334+233%
5 years ago$3,208+221%
→ See RadNet, Inc.'s full return history + gain calculator

Return by year (RadNet, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)-12%$880 (-12%)
2025+2%$899 (-10%)
2024+101%$1,806 (+81%)
→ See RadNet, Inc.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on RadNet, Inc.

Loading news…

📋 All analyst calls on RDNT

▲ Buy · 🎯$94
Price at call : $76.95 — upside +22%
Today : $75.36 — upside +25%
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 11, 27
Barclays 
May 20, 26
▲ Overweight · 🎯$65
Price at call : $54.44 — upside +19%
Today : $75.36 — upside -14%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 20, 27
Barclays 
Apr 21, 26
▲ Overweight · 🎯$70
Price at call : $57.83 — upside +21%
Today : $75.36 — upside -7%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Apr 21, 27
Keybanc 
Jan 9, 26
▲ Overweight · 🎯$92
Price at call : $76.35 — upside +20%
Today : $75.36 — upside +22%
🎯 on RDNT : no call matured yet · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jan 9, 27
▲ Buy · 🎯$87
Price at call : $78.8 — upside +10%
Today : $75.36 — upside +15%
🎯 on RDNT : 0% (1 call matured) · 📊 on Health : 48.6% · +36.7% (35 calls)
in progress (365j)
matures : Dec 1, 26
Barclays 
Nov 13, 25
▲ Overweight · 🎯$86
Price at call : $75.15 — upside +14%
Today : $75.36 — upside +14%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 13, 26
▲ Buy · 🎯$90
Price at call : $73.46 — upside +23%
Today : $75.36 — upside +19%
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 12, 26
Barclays 
Sep 3, 25
▲ Overweight · 🎯$79
Price at call : $72.3 — upside +9%
Today : $75.36 — upside +5%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Sep 3, 26
See the other 43 calls, newest to oldest
▲ Buy · 🎯$81
Price at call : $70.95 — upside +14%
Today : $75.36 — upside +7%
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Sep 3, 26
Raymond James 
Aug 13, 25
▲ Strong Buy · 🎯$75
Price at call : $68.41 — upside +10%
Today : $75.36 — upside -0%
Expected +10% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+13.0%
stock +13% · XLV +26%
matured Aug 13, 26
▲ Buy · 🎯$69
Price at call : $57.43 — upside +20%
Today : $75.36 — upside -8%
Expected +20% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 0% (1 call matured) · 📊 on Health : 48.6% · +36.7% (35 calls)
-0.7%
stock -1% · XLV +13%
matured Jun 13, 26
▲ Buy · 🎯$74
Price at call : $53.41 — upside +39%
Today : $75.36 — upside -2%
Expected +39% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+5.3%
stock +5% · XLV +8%
matured Apr 11, 26
Barclays 
Mar 24, 25
▲ Overweight · 🎯$60
Price at call : $51.83 — upside +16%
Today : $75.36 — upside -20%
Expected +16% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+15.5%
stock +16% · XLV -2%
matured Mar 24, 26
Raymond James 
Mar 5, 25
▲ Strong Buy · 🎯$65
Price at call : $51.58 — upside +26%
Today : $75.36 — upside -14%
Expected +26% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+17.6%
stock +18% · XLV +2%
matured Mar 5, 26
▲ Buy · 🎯$88
Price at call : $64.95 — upside +35%
Today : $75.36 — upside +17%
Expected +35% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+12.7%
stock +13% · XLV +9%
matured Jan 22, 26
Barclays 
Jan 22, 25
▲ Overweight · 🎯$74
Price at call : $63.73 — upside +16%
Today : $75.36 — upside -2%
Expected +16% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+14.5%
stock +14% · XLV +11%
matured Jan 22, 26
Jefferies 
Jan 15, 25
▲ Buy · 🎯$80
Price at call : $60.88 — upside +31%
Today : $75.36 — upside +6%
Expected +31% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
+16.6%
stock +17% · XLV +10%
matured Jan 15, 26
Jefferies 
Dec 5, 24
▲ Buy · 🎯$100
Price at call : $81.61 — upside +23%
Today : $75.36 — upside +33%
Expected +23% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
-6.7%
stock -7% · XLV +5%
matured Dec 5, 25
Barclays 
Dec 4, 24
▲ Overweight · 🎯$85
Price at call : $80.86 — upside +5%
Today : $75.36 — upside +13%
Expected +5% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+0.3%
stock +0% · XLV +5%
matured Dec 4, 25
▲ Buy · 🎯$94
Price at call : $82.85 — upside +13%
Today : $75.36 — upside +25%
Expected +13% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-3.4%
stock -3% · XLV +6%
matured Nov 29, 25
▲ Buy · 🎯$80
Price at call : $69.83 — upside +15%
Today : $75.36 — upside +6%
Expected +15% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+8.2%
stock +8% · XLV -11%
matured Sep 23, 25
Jefferies 
Sep 19, 24
▲ Buy · 🎯$80
Price at call : $69.34 — upside +15%
Today : $75.36 — upside +6%
Expected +15% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
+9.1%
stock +9% · XLV -12%
matured Sep 19, 25
Barclays 
Sep 6, 24
▲ Overweight · 🎯$79
Price at call : $62.41 — upside +27%
Today : $75.36 — upside +5%
Expected +27% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+15.3%
stock +15% · XLV -10%
matured Sep 6, 25
Barclays 
Aug 8, 24
■ Equal-Weight neutral · not a buy · 🎯$57
Price at call : $61.67 — gap to target -8%
Today : $75.36 — gap to target -24%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 8, 25
▲ Buy · 🎯$70
Price at call : $65.16 — upside +7%
Today : $75.36 — upside -7%
Expected +7% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-12.1%
stock -12% · XLV -10%
matured Jul 15, 25
Jefferies 
Jul 11, 24
▲ Buy · 🎯$75
Price at call : $61.41 — upside +22%
Today : $75.36 — upside -0%
Expected +22% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
-7.8%
stock -8% · XLV -9%
matured Jul 11, 25
Barclays 
Jul 11, 24
■ Equal-Weight neutral · not a buy · 🎯$51
Price at call : $59.84 — gap to target -15%
Today : $75.36 — gap to target -32%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 11, 25
▲ Buy · 🎯$63
Price at call : $57.58 — upside +9%
Today : $75.36 — upside -16%
Expected +9% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+6.2%
stock +6% · XLV -9%
matured May 15, 25
Raymond James 
May 10, 24
▲ Outperform · 🎯$60
Price at call : $55.72 — upside +8%
Today : $75.36 — upside -20%
Expected +8% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+2.4%
stock +2% · XLV -5%
matured May 10, 25
▲ Buy · 🎯$55
Price at call : $48.11 — upside +14%
Today : $75.36 — upside -27%
Expected +14% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+3.4%
stock +3% · XLV -0%
matured Mar 28, 25
Jefferies 
Mar 22, 24
▲ Buy · 🎯$58
Price at call : $47.03 — upside +23%
Today : $75.36 — upside -23%
Expected +23% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 50% · +9.9% (136 calls)
+10.2%
stock +10% · XLV +1%
matured Mar 22, 25
Barclays 
Mar 6, 24
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $48.5 — gap to target -1%
Today : $75.36 — gap to target -36%
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Mar 6, 25
▲ Buy · 🎯$51
Price at call : $46.84 — upside +9%
Today : $75.36 — upside -32%
Expected +9% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+10.7%
stock +11% · XLV +1%
matured Mar 4, 25
▲ Buy · 🎯$42
Price at call : $36.08 — upside +16%
Today : $75.36 — upside -44%
Expected +16% · Actual +119% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+118.7%
stock +119% · XLV +9%
matured Dec 7, 24
▲ Buy · 🎯$40
Price at call : $33.41 — upside +20%
Today : $75.36 — upside -47%
Expected +20% · Actual +98% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 80% (10 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+98.4%
stock +98% · XLV +18%
matured Aug 30, 24
Raymond James 
Jun 26, 23
▲ Outperform · 🎯$40
Price at call : $32.76 — upside +22%
Today : $75.36 — upside -47%
Expected +22% · Actual +76% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+76.1%
stock +76% · XLV +12%
matured Jun 25, 24
Raymond James 
May 10, 23
▲ Outperform · 🎯$35
Price at call : $28.26 — upside +24%
Today : $75.36 — upside -54%
Expected +24% · Actual +90% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+89.6%
stock +90% · XLV +8%
matured May 9, 24
CJS Securities
Mar 31, 23
▲ Outperform · 🎯$30
Price at call : $25.17 — upside +19%
Today : $75.36 — upside -60%
Expected +19% · Actual +91% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 100% (1 call matured) · 📊 on Health : 50% · +29.5% (6 calls)
+91.1%
stock +91% · XLV +12%
matured Mar 30, 24
Raymond James 
Mar 3, 23
▲ Outperform · 🎯$30
Price at call : $25.07 — upside +20%
Today : $75.36 — upside -60%
Expected +20% · Actual +87% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+86.8%
stock +87% · XLV +13%
matured Mar 2, 24
Raymond James 
Aug 12, 21
■ Market Perform neutral · not a buy
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Aug 12, 22
Barclays 
Aug 12, 21
▲ Overweight · 🎯$39
Price at call : $31.91 — upside +22%
Today : $75.36 — upside -48%
Expected +22% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 80% (5 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-30.3%
stock -30% · XLV +1%
matured Aug 12, 22
Raymond James 
Mar 9, 21
▲ Outperform · 🎯$26
Price at call : $23.18 — upside +12%
Today : $75.36 — upside -65%
Expected +12% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-8.1%
stock -8% · XLV +15%
matured Mar 9, 22
Raymond James 
Aug 11, 20
▲ Outperform · 🎯$22
Price at call : $17.52 — upside +26%
Today : $75.36 — upside -71%
Expected +26% · Actual +90% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+90.3%
stock +90% · XLV +25%
matured Aug 11, 21
Sidoti & Co.
May 26, 20
▲ Buy · 🎯$23
Price at call : $17.76 — upside +30%
Today : $75.36 — upside -69%
Expected +30% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
+51.4%
stock +51% · XLV +24%
matured May 26, 21
Sidoti & Co.
Feb 21, 20
▲ Buy · 🎯$28
Price at call : $23.1 — upside +21%
Today : $75.36 — upside -63%
Expected +21% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
-19.4%
stock -19% · XLV +10%
matured Feb 20, 21
Sidoti & Co.
Dec 2, 19
▲ Buy · 🎯$23
Price at call : $19.82 — upside +16%
Today : $75.36 — upside -69%
Expected +16% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
-5.3%
stock -5% · XLV +12%
matured Dec 1, 20
Sidoti & Co.
Nov 13, 19
▲ Buy · 🎯$20
Price at call : $15.87 — upside +26%
Today : $75.36 — upside -73%
Expected +26% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
+17.3%
stock +17% · XLV +17%
matured Nov 12, 20
Raymond James 
Nov 13, 19
▲ Outperform · 🎯$18.5
Price at call : $15.81 — upside +17%
Today : $75.36 — upside -75%
Expected +17% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+16.8%
stock +17% · XLV +16%
matured Nov 12, 20
Raymond James 
Mar 15, 19
▲ Outperform
Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-31.0%
stock -31% · XLV -11%
matured Mar 14, 20
Raymond James 
Mar 14, 18
▲ Strong Buy · 🎯$15
Price at call : $12.95 — upside +16%
Today : $75.36 — upside -80%
Expected +16% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+22.5%
stock +22% · XLV +7%
matured Mar 14, 19
Sidoti & Co.
Apr 15, 16
▲ Buy · 🎯$9
Price at call : $5.16 — upside +74%
Today : $75.36 — upside -88%
Expected +74% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on RDNT : 60% (5 calls matureds) · 📊 on Health : 54.2% · +25.8% (24 calls)
+15.3%
stock +15% · XLV +5%
matured Apr 15, 17

Frequently asked questions

Should I buy RadNet, Inc. stock?

This isn't buy advice. For RadNet, Inc., the analyst consensus is "Buy", with an average price target of $79.50 (+5% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 82% of the time (11 calls tracked on RadNet, Inc.). We show the numbers — you decide.

Is it too late to buy RadNet, Inc.? How high can it go?

The most bullish analyst target on RadNet, Inc. is $94.00 (+25% above today's price); the average is $79.50. That's the upside they see. Check how reliable those analysts have actually been on RadNet, Inc. on our site before trusting it.

Is RadNet, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on RadNet, Inc., the best hitting 82% over 11 calls. Current consensus: "Buy". Make your call on data, not noise.

What has RadNet, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: RDNT performance & returns.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)